MSC Therapy for Graft-versus-Host Disease: What 15 RCTs and a Biomarker-Guided Trial Tell Us

A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.

阅读更多...

Pediatric Applications of Stem Cell Therapy

Stem cell therapy holds immense promise for treating rare diseases in children, offering hope for conditions that are often difficult to manage with conventional treatments. Mesenchymal stem cells (MSCs) are particularly valuable in pediatric applications due to their safety and regenerative potential, addressing disorders like cerebral palsy, muscular dystrophy, and...

阅读更多...

Revolutionizing Cancer Treatment with CIK Cells

When it comes to modern medicine, advancements in cancer treatment and immune system rejuvenation are among the most exciting fields of study. One such breakthrough involves Cytokine-Induced Killer (CIK) cells. These specialized immune cells are showing promise in the fight against cancer and even offer potential for rejuvenating the immune...

阅读更多...

Hematopoietic Stem Cell Transplantation: An Advanced Treatment Option for Blood-Related Diseases

Hematopoietic stem cell transplantation (HSCT) is a medical procedure that involves the transplantation of stem cells that are capable of forming blood cells. This advanced treatment option is used to treat various blood-related diseases such as leukemia, lymphoma, and multiple myeloma. HSCT has been found to be highly effective in...

阅读更多...
Top